Mike Netz

Mike Netz possesses extensive experience in the investment and biomedical fields, currently serving on various boards and as an investor in health technology companies. Since January 2016, Mike has been a member of the BioMed Investment Committee at Club100Plus - Angels Group, while also holding board member and investor positions at SimHawk, QuantalX Neuroscience LTD, AEYE Health, and ORASIS PHARMACEUTICALS, among others. Mike's portfolio includes significant investments in companies such as ForSight Robotics and SignaLife. Educational qualifications include a Master of Business Administration in Marketing and International Management from Tel Aviv University and global executive education from INSEAD.